BKYI 10-Q: SEC filing
BIO-key International
Filed with the SEC on · accession 0001437749-26-036856
BKYI filed a 10-Q (quarterly report) with the SEC on Nov 13, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -17.8% by the first close after the filing.
Summary of the filing
BIO-key International filed its Q3 2026 Form 10-Q for the period ended September 30, 2026, reporting quarterly financial results and disclosing a reverse stock split effected April 30, 2026.
Key details
How BKYI stock reacted
Close before
$2.58
Nov 12, 2026
First close after
-17.83%
$2.12
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for BKYI, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for BKYI?
Click hereFrequently asked questions
What did BKYI file with the SEC on Nov 13, 2026?
BKYI filed a 10-Q (SEC filing). BIO-key International filed its Q3 2026 Form 10-Q for the period ended September 30, 2026, reporting quarterly financial results and disclosing a reverse stock split effected April 30, 2026.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did BKYI stock react to this filing?
BKYI closed at $2.58 before the filing and $2.12 on Nov 13, 2026 (-17.83%).
Other BKYI SEC filings
Get alerts when BKYI files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days